Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Michigan

Phase 2 colorectal cancer trials in Michigan

10 Phase 2 colorectal cancer studies are recruiting participants at sites in 20 cities across Michigan as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Michigan by city

Cities with the most studies recruiting right now.

Every Michigan city with a recruiting study

Detroit (4), Ann Arbor (3), Grand Rapids (3), Dearborn (2), Flint (2), Lansing (2), Troy (2), Bay City (1), Brighton (1), Canton (1), Chelsea (1), Clarkston (1), Farmington Hills (1), Lapeer (1), Livonia (1), Macomb (1), Petoskey (1), Port Huron (1), Royal Oak (1), Ypsilanti (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Michigan

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Grand Rapids
    Registry record
    NCT07659795 · updated
  2. Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Grand Rapids
    Registry record
    NCT04557449 · updated
  3. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Recruiting in
    Detroit
    Registry record
    NCT07446322 · updated
  4. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Ann Arbor · Brighton · Canton · and 10 more U.S. locations
    Registry record
    NCT05673148 · updated
  5. A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Ann Arbor
    Registry record
    NCT06820463 · updated
  6. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Ann Arbor
    Registry record
    NCT07023289 · updated
  7. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    • Phase 2
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Recruiting in
    Grand Rapids
    Registry record
    NCT05489211 · updated
  8. Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Endevica Bio
    Recruiting in
    Detroit
    Registry record
    NCT06937177 · updated
  9. Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer

    • Phase 2
    • Ages 22 and older
    • All sexes
    Sponsor
    Barbara Ann Karmanos Cancer Institute
    Recruiting in
    Bay City · Clarkston · Detroit · and 6 more U.S. locations
    Registry record
    NCT07130903 · updated
  10. A Study of IBI363 in Subjects with Advanced Solid Malignancies

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Innovent Biologics (Suzhou) Co. Ltd.
    Recruiting in
    Dearborn · Troy
    Registry record
    NCT06281678 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Michigan on ClinicalTrials.gov.

Ask about studies in Michigan

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call